DD272649A5 - Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel - Google Patents

Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel Download PDF

Info

Publication number
DD272649A5
DD272649A5 DD88312252A DD31225288A DD272649A5 DD 272649 A5 DD272649 A5 DD 272649A5 DD 88312252 A DD88312252 A DD 88312252A DD 31225288 A DD31225288 A DD 31225288A DD 272649 A5 DD272649 A5 DD 272649A5
Authority
DD
German Democratic Republic
Prior art keywords
tetrahydro
general formula
dimethyl
group
imidazo
Prior art date
Application number
DD88312252A
Other languages
German (de)
English (en)
Inventor
Alfred Mertens
Wolfgang Von Der Saal
Erwin Boehm
Klaus Strein
Original Assignee
��@���������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��@���������@�������k�� filed Critical ��@���������@�������k��
Publication of DD272649A5 publication Critical patent/DD272649A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Amplifiers (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DD88312252A 1987-01-17 1988-01-15 Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel DD272649A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873701277 DE3701277A1 (de) 1987-01-17 1987-01-17 Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DD272649A5 true DD272649A5 (de) 1989-10-18

Family

ID=6319010

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88312252A DD272649A5 (de) 1987-01-17 1988-01-15 Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel

Country Status (14)

Country Link
US (2) US4954498A (fi)
EP (1) EP0275888B1 (fi)
JP (1) JPS63192773A (fi)
KR (1) KR880009019A (fi)
AT (1) ATE103915T1 (fi)
DD (1) DD272649A5 (fi)
DE (2) DE3701277A1 (fi)
DK (1) DK14688A (fi)
FI (1) FI880182A (fi)
HU (1) HU205354B (fi)
IL (1) IL85069A0 (fi)
MX (1) MX10126A (fi)
PT (1) PT86561B (fi)
ZA (1) ZA88263B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
CA2095518A1 (en) * 1990-11-14 1992-05-15 Jeffrey M. Blaney Specific inhibition of dihydrofolate reductase and compounds therefor
WO1995006648A1 (en) * 1993-09-03 1995-03-09 Kyowa Hakko Kogyo Co., Ltd. Imidazoquinazoline derivative
US5476851A (en) * 1994-09-08 1995-12-19 Rhone-Poulenc Rorer Pharmaceuticals, Inc. Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase
AU8689298A (en) * 1997-08-05 1999-03-01 Sugen, Inc. Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
US5932580A (en) * 1997-12-01 1999-08-03 Yissum Research And Development Company Of The Hebrew University Of Jerusalem PDGF receptor kinase inhibitory compounds their preparation and compositions
US6114532A (en) * 1998-02-03 2000-09-05 Boehringer Ingelheim Pharma Kg Bicyclic heterocycles, the preparation thereof, and their use as pharmaceuticals
WO1999040072A1 (de) * 1998-02-03 1999-08-12 Boehringer Ingelheim Pharma Kg 5-gliedrige benzokondensierte heterocyclen als antithrombotika
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
EP1091939A1 (en) * 1998-06-30 2001-04-18 Du Pont Pharmaceuticals Company Substituted quinolin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
US6358954B1 (en) * 1999-11-09 2002-03-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
US6423844B1 (en) 2001-06-06 2002-07-23 The United States Of America As Represented By The Secretary Of The Navy Process for making 1,2,4-triazolo[4,3-a][1,3,5]triazine-3,5,7-triamine
EP2033953A1 (en) * 2002-02-15 2009-03-11 Glaxo Group Limited Vanilloid receptor modulators
US7470712B2 (en) * 2004-01-21 2008-12-30 Bristol-Myers Squibb Company Amino-benzazoles as P2Y1 receptor inhibitors
US7285569B2 (en) 2004-09-24 2007-10-23 Hoff Hoffmann-La Roche Inc. Tricycles, their manufacture and use as pharmaceutical agents
US20060142247A1 (en) * 2004-12-17 2006-06-29 Guy Georges Tricyclic heterocycles
CN101160312A (zh) * 2005-04-14 2008-04-09 霍夫曼-拉罗奇有限公司 三环吡咯衍生物、它们的制备和作为药剂的应用
WO2006108489A1 (en) * 2005-04-14 2006-10-19 F. Hoffmann-La Roche Ag Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
AU2006326247A1 (en) * 2005-12-15 2007-06-21 F. Hoffmann-La Roche Ag Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents
CN101400681A (zh) * 2006-03-23 2009-04-01 霍夫曼-拉罗奇有限公司 取代的吲唑衍生物,它们的制备和作为药剂的应用
WO2013071306A1 (en) * 2011-11-11 2013-05-16 The Regents Of The University Of Colorado Topoisomerase inhibitors and methods of making and use as therapeutic agents
SG11201602572YA (en) 2013-10-03 2016-04-28 Kura Oncology Inc Inhibitors of erk and methods of use
WO2019043208A1 (en) 2017-09-04 2019-03-07 F. Hoffmann-La Roche Ag DIHYDROQUINOLINONES
AU2019315444A1 (en) * 2018-07-31 2021-02-11 The Trustees Of Princeton University Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers
CN117897370A (zh) * 2021-04-22 2024-04-16 凯悦施那有限公司 杂环化合物和其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148930B (fi) * 1977-09-19 1981-07-25 Hoffmann La Roche
US4352931A (en) * 1980-05-22 1982-10-05 Siegfried Aktiengesellschaft Lin-benzoaminopurinols
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3410168A1 (de) * 1984-03-20 1985-09-26 Boehringer Mannheim Gmbh, 6800 Mannheim Neue isochinolin-dione, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3445669A1 (de) * 1984-12-14 1986-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3524067A1 (de) * 1985-07-05 1987-01-08 Boehringer Mannheim Gmbh Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte

Also Published As

Publication number Publication date
HU205354B (en) 1992-04-28
MX10126A (es) 1993-11-01
KR880009019A (ko) 1988-09-13
IL85069A0 (en) 1988-06-30
HUT46915A (en) 1988-12-28
FI880182A (fi) 1988-07-18
EP0275888A3 (en) 1989-09-27
DK14688A (da) 1988-07-18
US4954498A (en) 1990-09-04
PT86561A (de) 1988-02-01
DE3888854D1 (de) 1994-05-11
EP0275888B1 (de) 1994-04-06
ATE103915T1 (de) 1994-04-15
FI880182A0 (fi) 1988-01-15
JPS63192773A (ja) 1988-08-10
PT86561B (pt) 1991-12-31
AU605822B2 (en) 1991-01-24
ZA88263B (en) 1988-06-29
AU1031688A (en) 1988-07-21
DK14688D0 (da) 1988-01-13
US5116843A (en) 1992-05-26
EP0275888A2 (de) 1988-07-27
DE3701277A1 (de) 1988-07-28

Similar Documents

Publication Publication Date Title
DD272649A5 (de) Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3935514A1 (de) Neue bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3932953A1 (de) Neue 2-bicyclo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0533058A1 (de) Imidazo-annellierte Iso- und Heterocyclen, Antagonisten als Angiotensin II
DE4031287A1 (de) Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3522230A1 (de) Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3642315A1 (de) Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
EP0266558A2 (de) 5-Alkylbenzimidazole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0344634B1 (de) Bicyclische Carboxamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0186010B1 (de) Neue Pyrrolo-Benzimidazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD255344A5 (de) Heteroaryl-oxy-beta-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3530825A1 (de) Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD253821A5 (de) Verfahren zur herstellung von pyrrolo-benzimidozolen, pyrrolo-benzooxazolen und pyrrolo-benzthiozole
DE3346575A1 (de) Neue benzimidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE4027592A1 (de) Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
DE3346640A1 (de) Neue imidazolderivate, deren herstellung und diese verbindungen enthaltende arzneimittel
EP0207483A2 (de) Neue Benzimidazole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel sowie Zwischenprodukte
EP0047412B1 (de) Neue Pyrazine, deren Herstellung und diese enthaltende Arzneimittel
DD272081A5 (de) Verfahren zur herstellung neuer pyrrolo-benzinmidazolen
CH641800A5 (de) Pyrido-pyrimidine, verfahren zu ihrer herstellung und die diese verbindungen enthaltenden arzneimittel.
DE3446417A1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
CH648847A5 (de) 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimidin-4-on-derivate und verfahren zu ihrer herstellung.
DE4031601A1 (de) Heterocyclische imidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4131325A1 (de) Imidazo-annellierte iso und heterocyclen, verfahren zu deren herstellung, sie enthaltende mittel und ihre verwendung
DE4025358A1 (de) Heterocyclische imidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung